What is TheraTrue?
TheraTrue operates as a specialized medical cannabis enterprise, distinguishing itself through a heavy emphasis on scientific validation and clinical integrity. The organization is governed by a Medical Advisory Board comprising over 20 physicians and pharmacists, ensuring that every product meets stringent safety and efficacy benchmarks. As a majority Black-owned entity, TheraTrue integrates a commitment to diversity and inclusivity directly into its corporate governance, setting a new standard for social responsibility within the cannabis sector. The company focuses on providing reliable, high-quality medicinal products for patients managing qualified medical conditions, effectively positioning itself as a trusted partner in the healthcare ecosystem.
How much funding has TheraTrue raised?
TheraTrue has raised a total of $50M across 1 funding round:
Unspecified
$50M
Unspecified (2021): $50M, investors not publicly disclosed
Key Investors in TheraTrue
TheraTrue
Undisclosed investor participating in the funding round.
TheraTrue
Undisclosed investor participating in the funding round.
TheraTrue
Undisclosed investor participating in the funding round.
What's next for TheraTrue?
With the recent influx of capital, TheraTrue is strategically positioned to scale its research and development initiatives. The company is expected to focus on expanding its clinical trial participation and refining its supply chain to ensure consistent, pharmaceutical-grade quality across its product lines. Furthermore, the organization will likely leverage its current momentum to deepen its market penetration, utilizing its unique position as a minority-led firm to foster partnerships with healthcare providers and institutions. As the regulatory environment for medical cannabis continues to mature, TheraTrue's focus on evidence-based outcomes will be critical in navigating future growth phases and maintaining its competitive advantage in the therapeutic market.
See full TheraTrue company page
